Endocrinologic and psychological effects of short-term dexamethasone in anorexia nervosa

Eating and Weight Disorders

Volumn 5, Issue 3, 2000, Pages 175-182

  Gordon, C M ^a   Emans, S J ^a   DuRant, R H ^b   Mantzoros, C ^c   Grace, E ^a   Harper, G R ^a   Majzoub, J A ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Anorexia nervosa; Corticotropin releasing hormone; Glucocorticoids

Indexed keywords

CORTICOTROPIN; DEXAMETHASONE; GLUCOCORTICOID; HYDROCORTISONE; INSULIN; LEPTIN;

ADOLESCENT; ADULT; ANOREXIA NERVOSA; ARTICLE; BLOOD; DEPRESSION; DRUG ADMINISTRATION; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM; PILOT STUDY; PSYCHOLOGICAL ASPECT; TREATMENT OUTCOME;

ADOLESCENT; ADRENOCORTICOTROPIC HORMONE; ADULT; ANOREXIA NERVOSA; BLOOD GLUCOSE; DEPRESSION; DEXAMETHASONE; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INSULIN; LEPTIN; PILOT PROJECTS; PITUITARY-ADRENAL SYSTEM; TREATMENT OUTCOME;

EID: 0034279848     PISSN: 11244909     EISSN: 15901262     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Gold P.W., Gwirtsman H., Avgerinos P.C., Nieman L.K., Gallucci W.T., Kaye W., Jimerson D., Ebert M., Rittmaster R., Loriaux D.L.: Abnormal hypothalamic-pitu-itary-adrenal function in anorexia nervosa: Pathophysiologic mechanisms in underweight and weight-corrected patients. N. Engl. J. Med., 314, 1335-1342, 1986.
2. Licinio J., Wong M., Gold P.W.: The hypo-thalamic-pituitary-adrenal axis in anorexia nervosa. Psychiatr. Res., 62, 75-83, 1996.
3. Bliss E.L., Migeon C.J.: Endocrinology of anorexia nervosa. J. Clin. Endocrinol. Metab., 17, 766-776, 1957.
4. Boyar R.M., Hellman L.D., Roffwarg H., Katz J., Zumoff B., O'Conner J., Bradlow H.L., Fuushima D.L.: Cortisol secretion and metabolism in anorexia nervosa. N. Engl. J. Med., 296, 190-193, 1977.
5. Doerr P., Fichter M., Pirke K.M., Lund R.: Relationship between weight gain and hypothalamic pituitary adrenal function in patients with anorexia nervosa. J. Steroid Biochem., 13, 529-573, 1985.
6. Walsh B.T., Roose S.P., Katz J.L., Dyrenfurth I., Wright L., Wiele R.V., Glassman A.H.: Hypothalamic-pituitary-adrenocortical activity in anorexia nervosa and bulimia. Psychoneuroendocrinology, 12, 131-140, 1987.
7. Walsh B.T., Katz J.L., Levin J., Kream J., Fukushima D.K., Hellman D., Weiner F.L., Zumoff B.: Adrenal activity in anorexia nervosa. Psychosom. Med., 40, 499-506, 1978.
8. Schweitzer I., Szmukler G.I., Maguire K.P., Harrison L.C., Tuckwell V., Davies B.M.: The dexamethasone suppression test in anorexia nervosa. The influence of weight, depression, adrenocorticotropic hormone and dexamethasone. Br. J. Psychiatry, 157, 713-717, 1990.
9. Gwirtsman H.E., Kay W.H., George D.T.: Central and peripheral ACTH and Cortisol levels in anorexia and bulimia. Arch. Gen. Psychiatry, 46, 61, 1989.
10. Hotta M., Shibasaki T., Masuda A., Imaki T., Demura F.L., Ling N., Shimzume K.: The response of plasma adrenocorticotropin and Cortisol to corticotropin-releasing hormone (CRH) and cerebrospinal fluid immunoreactive CRH in anorexia nervosa patients. J. Clin. Endocrinol. Metab., 62, 319-324, 1986.
11. Kling M.A., Demitrack M.A. Jr., Whitfield HJ., Kalogeras K.T., Listwal S.J., DeBellis M.D., Churousos G.P., Gold P.W., Brandt H.A.: Effects of glucocorticoid antagonist RU 486 on pituitary-adrenal function in patients with anorexia nervosa and healthy volunteers: enhancement of plasma ACTH and Cortisol secretion in underweight patients. Neuroendocrinology, 57, 1082-1091, 1993.
12. Kaye W.H., Gwirtsman H.E., George D.T., Ebert M.H., Jimmerson D. C, Tomai T.P., Churousos G.P., Gold P.W.: Elevated cerebrospinal fluid levels of immunoreactive corticotropin-releasing hormone in anorexia nervosa: relation to state of nutrition, adrenal function, and intensity of depressions. J. Clin. Endocrinol. Metab., 62, 203-208, 1987.
13. Rivier C, Rivier J., Vale W.: Stress-induced inhibition of reproductive functions: role of endogenous corticotropin-releasing factor. Science, 231, 607-609, 1986.
14. Sutton R.E., Koob G.F., LeMoul M., LeMoal M., Rivier J., Vale W.: Corticotropin releasing factor produces behavioral activation in rats. Nature, 293, 331-333, 1982.
15. Jeong K.H., Jacobson L., Widmaier E.P., Majzoub J.A.: Normal suppression of the reproductive axis following stress in corti-cotropin-releasing-hormone- deficient mice. Endocrinology, 140, 1702-1708, 1999.
16. Jacobson L.: Glucocorticoid replacement, but not corticotropin-releasing hormone deficiency, prevents adrenalectomy-induced anorexia in mice. Endocrinology, 140, 310-317, 1999.
17. Weninger S.C., Muglis S.J., Jacobs M.L., Majzoub J.A.: CRH is not required for decreases in food intake during chronic stress. Regul. Pept., 1999b.
18. Weninger S., Dunn A., Muglia L., Dikkes P., Miczek K., Swiergiel A., Berridge C., Majzoub J.: Stress-induced behaviors require the CRH receptor, but not CRH. Proc. Natl. Acad. Sci. USA, 1999a.
19. Kiss A., Jezova D., Augilera G.: Activity of the hypothalamic-pituitary- adrenal axis and sympathoadrenal system during food and water deprivation in the rat. Brain Res., 663, 84-92, 1999.
20. Muglia L.J., Jacobson L., Dikkes P., Majzoub J.A.: Corticotropin- releasing hormone deficiency reveals major fetal but not adult glucocorticoid need. Nature, 373, 427-432, 1995.
21. Gudmundsson K., Majzoub J.: CRH deficiency attenuates weight loss independent of effects on food intake. Abstract OR33-1, Annual Meeting, The Endocrine Society, New Orleans, LA., 1998.
22. Beck A.T.: Depression. Philadelphia, University of Pennsylvania Press, 1967.
23. Garner D.M., Olmsted M.P., Bohr Y., Garfinkel P.E.: The eating attitudes test: Psychometric features and clinical correlates. Psychol. Med., 12, 871-878, 1982.
24. Piazza E., Rollins N., Lewis F.S.: Measuring severity and change in anorexia nervosa. Adolescence, 70, 293-305, 1983.
25. Rolls B.J., Anderson A.E., Moran T.H., McNelis A.L., Baier H.C., Federoff I.C.: Food intake, hunger and satiety after preloads in women with eating disorders. Am. J. Clin. Nutr., 60, 476-487, 1989.
26. Rolls B.J., Kim-Harris S., Fischman M.W., Foltin R.W., Moran T.H., Stoner S.A.: Satiety after preloads with different amounts of fat and carbohydrate: implications for obesity. Am. J. Clin. Nutr., 60, 476-478, 1994.
27. Sepple, C.P., Read, N.W.: Gastrointestinal correlates of the development of hunger in man. Appetite, 13, 183-191, 1989.
28. Ahima R.S., Prabakaran D., Mantzoros C, Qu D., Lowell B., Maratos-Flier E., Flier J.S.: Role of leptin in the neuroendocrine response to fasting. Nature, 382, 250-252, 1998.
29. Audi L., Mantzoros C.S., Vidal-Puig A., Vargas D., Guissinye M., Carrascosa A.: Leptin in relation to resumption of menses in women with anorexia nervosa. Mol. Psychol., 3, 544-547, 1998.
30. Barash I.A., Cheung C.C., Weigle D.S., Ren H., Kabigting E.B., Kuijper J.L., Clifton D.K., Steiner R.A.: Leptin is a metabolic signal to the reproductive system. Endocrinology, 137, 3144-3147, 1996.
31. Mantzoros C: The role of leptin in human obesity and disease: a review of current evidence. Ann. Intern. Med., 130, 671-680, 1999.
32. Kautzky-Willer A., Thomaseth K., Clodi M., Ludrik B., Walshausl W., Prager R., Pacini G.: Beta-cell activity and hepatic insulin extraction following dexamethasone administration in healthy subjects. Metabolism, 45, 486-491, 1996.
33. Ludvik B., Clodi M., Kautzky-Willer A., Capek M., Hartter E., Pacini G., Prager R.: Effect of dexamethasone on insulin sensitivity, islet amyloid polypeptide and insulin secretion in humans. Diabetologia, 36, 84-87, 1993.
34. Yashuda K., Hines E., Kitabachi A.E.: Hypercortisolism and insulin resistance: Comparative effects of prednisone, hydrocortisone and dexamethasone on insulin binding of human erythrocytes. J. Clin. Endocrinol. Metab., 55, 910-915, 1982.
35. Nozaki T., Tamai H., Matsubayashi S., Komaki G., Kobayashi N., Nakagawa T.: Insulin response to intravenous glucose in patients with anorexia nervosa showing low insulin response to oral glucose. J. Clin. Endocrinol. Metab., 79, 311-314, 1994.
36. Castillo M., Scheen A., Lefebvre P.J., Luyckx A.S.: Insulin-stimulated glucose disposal is not increased in anorexia nervosa. J. Clin. Endocrinol. Metab., 60, 311-314, 1985.
37. Zuniga-Guajardo S., Garfinkel P.E., Zinman B.: Changes in insulin sensitivity and clearance in anorexia nervosa. Metabolism, 85, 1096-1100, 1986.
38. Grinspoon S., Gulick T., Askari H., Landt M., Lee K., Anderson E., Ma Z., Vignati L., Bowsher R., Herzog D., Klibanski A.: Serum leptin levels in women with anorexia nervosa. J. Clin. Endocrinol. Metab., 81, 3861-3863, 1996.
39. Wang J., Liu R., Hawkins M., Barzilai N., Rossetti L.: A nutrient-sensing pathway regulates leptin gene expression in muscle and fat. Nature, 393, 684-688, 1998.
40. Wabitsch M. Jensen P.B., Blum W.F., Christoffersen CT., Englaro P., Heinze E., Rascher W., Teller W., Tornqvist H., Hauner H.: Insulin and Cortisol promote leptin production in cultured human fat cells. Diabetes, 45, 1435-1438, 1996.
41. Larsson H., Ahren B.: Short-term dexamethasone treatment increases plasma leptin independently of changes in insulin sensitivity in healthy women. J. Clin. Endocrinol. Metab., 81, 4428-4432, 1996.
42. Papaspyrou-Rao S., Schneider S.H., Petersen R.N., Fried S.K.: Dexamethasone increases leptin expression in humans in vivo. J. Clin. Endocrinol. Metab. 82: 1635-1637, 1997.
43. Garfinkel P.E., Kaplan A.S.: Anorexia nervosa: Diagnostic conceptualizations. In: Brownell K.D., Forey J.P. (Eds.), Handbook of Eating Disorders. New York, Basic Books, 1987, pp. 266-282.